Abstract

Diabetic foot ulcer is classified as a chronic non-healing wound and its clinical definition is a non-healing sore or wound occurring in foot. As per WHO, more than 500 million people have diabetes globally, and typically approximately 100 million diabetic patients develop diabetic foot ulcer. There is a distinct lack of substantial treatment for diabetic foot ulcers that leads to healing. Foot amputation, wound dressings and continued wound care are the standard of practices for diabetic foot ulcer treatment. The prevalent standard treatment for diabetic foot ulcers are not adequate and require a considerable loss of the ability of the patient to lead a normal. Healthy life. There is a distinct gap in the market for the treatment of diabetic chronic foot wound. The use of stem cells in wound healing is an under-research area and there are presently only a handful of products available commercially that can be classified as gene therapy treatments for diabetic foot ulcers.